NEW DELHI: India’s pharmaceutical industry has sought at least two more years to implement the revised pharma manufacturing rules under Schedule M, saying it is necessary to ensure survival of micro, small and medium enterprises (MSMEs).Schedule M of the Drugs and Cosmetics Rules, 1945 prescribes the good manufacturing practices (GMP) for pharmaceutical products, such as a prompt product recall system for products known or suspected to be defective. Pharma lobby groups have written to the…
Read More…
Pharma companies seek more time to implement revised norms on manufacturing practices
